Abstract
In the present study, a series of benzothiazolylindenopyrazoles 5a‒o has been efficiently synthesized by refluxing a solution of 2-(3-substitutedbenzoyl)-(1H)-indene-1,3(2H)-diones 1a–c and 2-hydrazinylbenzo[d]thiazole/2-hydrazinyl-6-substitutedbenzo[d]thiazoles 4a–e in presence of dry ethanol and glacial acetic acid in good yields. The newly synthesized derivatives 5a‒o were well characterized by using different physical and spectral techniques (FTIR, 1H NMR, 13C NMR and HRMS). All the derivatives 5a‒o were subjected to their preliminary antimicrobial assay against two Gram-positive bacterial strains [Bacillus subtilis (MTCC 441) and Staphylococcus aureus (MTCC 7443)], two Gram-negative bacterial strains [Escherichia coli (MTCC 1652) and Pseudomonas aeruginosa (MTCC 424)], and two fungal strains [Candida albicans (MTCC 227) and Aspergillus niger (MTCC 8189)] employing serial dilution method using Ciprofloxacin and Fluconazole as standard drugs for bacterial and fungal strains, respectively. Among all the tested derivatives, 5m (MIC = 0.0255 µmol/mL) and 5o (MIC = 0.0232 µmol/mL) exhibited maximal inhibition against fungal strain C. albicans. Overall, the investigation revealed that the titled compounds were found more potent against C. albicans.
Similar content being viewed by others
References
Farha MA, Brown ED. Drug repurposing for antimicrobial discovery. Nat Microbiol. 2019;4:565–7.
Boucher HW, Talbot GH, Bradley JS. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1–12.
Manandhar S, Luitel S, Dahal RK. In vitro antimicrobial activity of some medicinal plants against human pathogenic bacteria. J Trop Med. 2019;2019:1–5.
Trigo-Gutierrez JK, Vega-Chacón Y, Soares AB, Mima EGDO. Antimicrobial activity of curcumin in nanoformulations: a comprehensive review. Int J Mol Sci. 2021;22:7130–78.
Eftekhari-Sis B, Zirak M, Akbari A. Arylglyoxals in Synthesis of Heterocyclic Compounds. Chem Rev. 2013;113:2958–3043.
Ansari A, Ali A, Asif M. Biologically active pyrazole derivatives. N. J Chem. 2017;41:16–41.
Ju Y, Varma RS. Aqueous N-Heterocyclization of Primary Amines and Hydrazines with Dihalides: Microwave-Assisted Syntheses of N-Azacycloalkanes, Isoindole, Pyrazole, Pyrazolidine, and Phthalazine Derivatives. J Org Chem. 2006;71:135–41.
Zárate-Zárate D, Aguilar R, Hernández-Benitez RI, Labarrios EM, Delgado F, Tamariz J. Synthesis of α-ketols by functionalization of captodative alkenes and divergent preparation of heterocycles and natural products. Tetrahedron. 2015;71:6961–78.
Faisal M, Saeed A, Hussain S, Dar P, Larik FA. Recent developments in synthetic chemistry and biological activities of pyrazole derivatives. J Chem Sci. 2019;131:1–30.
Karrouchi K, Radi S, Ramli Y, Taoufik J, Mabkhot YN, Al-Aizari FA, et al. Synthesis and pharmacological activities of pyrazole derivatives: A review. Molecules. 2018;23:134–219.
Mor S, Khatri M, Punia R, Sindhu S. Recent Progress in Anticancer Agents Incorporating Pyrazole Scaffold. Mini-Rev Med Chem. 2022;22:115–63.
Mor S, Khatri M, Punia R, Nagoria S, Sindhu S. A new insight into the synthesis and biological activities of pyrazole based derivatives. Mini-Rev Org Chem. 2022;19:717–78.
Bakr FAW, Kamal MD. Synthesis and applications of bipyrazole systems. ARKIVOC. 2012;491:491–545.
Ahsan MJ, Samy JG, Soni S, Jain N, Kumar L, Sharma LK, et al. Discovery of novel antitubercular 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide/carbothioamide analogues. Bioorg Med Chem Lett. 2011;21:5259–61.
Ahsan MJ, Samy JG, Khalilullah H, Bakht MA, Hassan MZ. Synthesis and antimycobacterial evaluation of 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide analogues. Eur J Med Chem. 2011;46:5694–7.
Lemke TL, Cramer MB, Shanmugam K. Heterocyclic tricycles as potential CNS agents I: 4-aminoalkylindeno[1,2-c]pyrazoles. J Pharma Sci. 1978;67:1377–81.
Loev B, Mosher WA. Pyrazoloindenone azines. 1961; U.S. Patent No. 2,969,374.
Angelone T, Caruso A, Rochais C, Caputo AM, Cerra MC, Dallemagne P, et al. Indenopyrazole Oxime Ethers: Synthesis and ß1-Adrenergic Blocking Activity. Eur J Med Chem. 2015;92:672–81.
Murineddu G, Lazzari P, Ruiu S, Sanna A, Loriga G, Manca I, et al. Tricyclic Pyrazoles. 4. Synthesis and Biological Evaluation of Analogues of the Robust and Selective CB2 Cannabinoid Ligand 1-(2ˈ,4ˈ-Dichlorophenyl)-6-methyl-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide. J Med Chem. 2006;49:7502–12.
Ahsan MJ, Govindasamy J, Khalilullah H, Mohan G, Stables JP, Pannecouque C, et al. POMA analyses as new efficient bioinformatics’ platform to predict and optimise bioactivity of synthesized 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide/carbothioamide analogues. Bioorg Med Chem Lett. 2012;22:7029–35.
Hamilton RW. The antiarrhythmic and antiinflammatory activity of a series of tricyclic pyrazoles. J Heterocycl Chem. 1976;13:545–53.
Shareef MA, Sirisha K, Khan I, Sayeed IB, Jadav SS, Ramu G, et al. synthesis, and antimicrobial evaluation of 1,4-dihydroindeno[1,2-c]pyrazole tethered carbohydrazide hybrids: exploring their in silico ADMET, ergosterol inhibition and ROS inducing potential. Med Chem Comm. 2019;10:806–13.
Mor S, Khatri M. Synthesis, antimicrobial evaluation, α-amylase inhibitory ability and molecular docking studies of 3-alkyl-1-(4-(aryl/heteroaryl)thiazol-2-yl)indeno[1,2-c]pyrazol-4(1H)-ones. J Mol Struct. 2022;1249:131526–35.
Minegishi H, Futamura Y, Fukashiro S, Muroi M, Kawatani M, Osada H, et al. Methyl 3-((6-methoxy-1,4-dihydroindeno [1,2-c]pyrazol-3-yl) amino)benzoate (GN39482) as a tubulin polymerization inhibitor identified by MorphoBase and ChemProteoBase profiling methods. J Med Chem. 2015;58:4230–41.
Shahlaei M, Fassihi A, Saghaie L, Arkan E, Madadkar-Sobhani A, Pourhossein A. Computational evaluation of some indenopyrazole derivatives as anticancer compounds; application of QSAR and docking methodologies. J Enz Inhib Med Chem. 2013;28:16–32.
Liu YN, Wang JJ, Ji YT, Zhao GD, Tang LQ, Zhang CM, et al. Design, synthesis, and biological evaluation of 1-methyl-1, 4-dihydroindeno[1,2-c]pyrazole analogues as potential anticancer agents targeting tubulin colchicine binding site. J Med Chem. 2016;59:5341–55.
Khan I, Shareef MA, Kumar GC. An overview on the synthetic and medicinal perspectives of indenopyrazoles. Eur J Med Chem. 2019;178:1–12.
Pathak N, Rathi E, Kumar N, Kini SG, Rao CM. A review on anticancer potentials of benzothiazole derivatives. Mini-Rev Med Chem. 2020;20:12–23.
Tariq S, Kamboj P, Amir M. Therapeutic advancement of benzothiazole derivatives in the last decennial period. Arch der Pharmazie. 2019;352:1800170–86.
Keri RS, Patil MR, Patil SA, Budagumpi SA. Comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry. Eur J Med Chem. 2015;89:207–51.
Gunawardana GP, Kohmoto S, Gunasekera SP, McConnell OJ, Koehn FE. Dercitine, a new biologically active acridine alkaloid from a deep water marine sponge, Dercitus sp. J Am Chem Soc. 1988;110:4856–8.
Mor S, Sindhu S. Synthesis, Type II diabetes inhibitory activity, antimicrobial evaluation and docking studies of indeno[1,2-c]pyrazol-4(1H)-ones. Med Chem Res. 2020;29:46–62.
Kilgore LB, Ford JH, Wolfe WC. Insecticidal properties of 1,3-indandiones. Ind Eng Chem. 1942;34:494–7.
Dhawan SN, Mor S, Sharma K, Chawla AD, Saini A, Gupta SC. On the mechanism of formation of pyrazoles from 1,3-diketones and hydrazines: isolation of hydroxypyrazoline intermediates. Indian J Chem Sect B. 1994;33:38–42.
Gupta SC, Quarishi MA, Dhawan SN. Synthesis of 6-phenyl-7H-indeno[2,1-c]quinoline and 2-methyl-6-phenyl-7H-indeno[2,1-c]quinoline. Indian J Chem Sect B. 1979;18:547–8.
Hugerschoff H. Effect of bromine on aromatic thioureas. Chem Ber. 1903;36:3121–34.
Mor S, Mohil R, Nagoria S, Kumar A, Lal K, Kumar D, et al. Regioselective synthesis, antimicrobial evaluation and QSAR studies of some 3‐aryl‐1‐heteroarylindeno[1,2‐c]pyrazol‐4(1H)‐ones. J Heterocycl Chem. 2017;54:1327–41.
Mor S, Nagoria S. Efficient and convenient synthesis, characterization, and antimicrobial evaluation of some new tetracyclic 1,4-benzothiazines. Synth Commun. 2016;46:169–78.
Acknowledgements
The authors are highly thankful to the University Grants Commission, New Delhi, India [Sr.No. 2061610093 Ref.No.19/06/2016(i)EU-V, dated 26-12-2016] and Council of Scientific & Industrial Research, New Delhi [CSIR no. 09/752(0104)/2019-EMR-I] for providing financial support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Mor, S., Khatri, M., Punia, R. et al. Synthesis and in vitro antimicrobial evaluation of benzothiazolylindenopyrazoles. Med Chem Res 32, 47–56 (2023). https://doi.org/10.1007/s00044-022-02988-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-022-02988-7